TerraTox - HIV-1 structure file, May 2004. Copyright ... - TerraBase Inc.

4136 C29H50N4O11SSi2
4137 C29H51N5O10SSi2 TSAO deriv.; T-4126-007
[1-[2',5'-bis(-O-(tert-butyldimethylsilyl)-beta-D-
ribofuranosyl]-3-N-[[N-[1-(S)-
(carboxy)ethyl]carbamoyl]methyl]thymine]-3'-spiro-5''-
(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)
[C@]12(OS(=O)(=O)C=C1N)[C@@H](CO[Si](C)(C)C(C)(C)C)O[C@H]([C@@H]2O[Si](C)(C
)C(C)(C)C)N3C=C(C)C(=O)N(C3=O)CC(=O)N[C@H](C)C(=O)O
O1S(=O)(=O)C(CC(=O)N)=C(NCC(=O)N)[C@]12[C@@H](CO[Si](C)(C)C(C)(C)C)O[C@H]([
C@@H]2O[Si](C)(C)C(C)(C)C)N3C=C(C)C(=O)N(C)C3=O
4138 C30H16O8 hypericin Oc1cc(O)c2c3c(O)cc(O)c4C(=O)c5c(O)cc(C)c6c7c(C)cc(O)c(c7C8=C(c56)c34)C(=O)c1c28 548-04-9
4139 C30H20N2O7
2(E)-(3-hydrox-5-((E)-7-carboxy-8-hydroxyquinolin-2-
yl)ystyryl)-7-carboxy-8-hydroxyquinoline
Oc1c(C(=O)O)ccc2ccc(nc12)/C=C/c3cc(O)cc(/C=C/c4ccc5ccc(C(=O)O)c(O)c5n4)c3
4140 C30H26O16 L-chicoric acid tetraacetate
c1cc(OC(=O)C)c(OC(=O)C)cc1/C=C/C(=O)O[C@@H](C(=O)O)[C@H](C(=O)O)OC(=O)/C=
C/c2ccc(OC(=O)C)c(OC(=O)C)c2
4141 C30H26O16 D-chicoric acid tetraacetate
c1cc(OC(=O)C)c(OC(=O)C)cc1/C=C/C(=O)O[C@H](C(=O)O)[C@@H](C(=O)O)OC(=O)/C=
C/c2ccc(OC(=O)C)c(OC(=O)C)c2
4142 C30H27IN2O quaternary ammonium salt; 4128-106 c1ccccc1c2ccc3CCC(=Cc3c2)C(=O)Nc4ccc(cc4)C[n+]5c(C)cccc5.[I-]
4143 C30H30N2O6S cyclic urea/diaminosulfone deriv.; T-4269-004
c1ccccc1CN2S(=O)(=O)N(Cc3ccccc3)[C@H](Oc4ccccc4)[C@H](O)[C@@H](O)[C@H]2Oc
5ccccc5
4144 C30H31IN4O5S2 cyclic sulfondiamide deriv.; T-4409-017
O[C@H]1[C@@H](Cc2ccccc2)N(CC(=O)Nc4nccs4)S(=O)(=O)N(Cc4cc(I)ccc4)[C@H](Cc3c
cccc3)[C@@H]1O
4145 C30H32N4O5S2 cyclic sulfondiamide deriv.; T-4409-013
O[C@H]1[C@@H](Cc2ccccc2)N(CC(=O)Nc4nccs4)S(=O)(=O)N(Cc4ccccc4)[C@H](Cc3ccc
cc3)[C@@H]1O
4146 C30H32N8O5
phthalimide-[N]-(Dist-deriv); Dist-deriv= Distamycin
derivative with dimethylaminopropyl end
O=C(N4c1cn(C)c(c1)C(=O)Nc2cn(C)c(c2)C(=O)Nc3cnc(c3)C(=O)NCCCN(C)C)c1ccccc1C4
=O
4147 C30H33Cl2NO10
methyl 5-[4-(4',4''-dimethoxy-3',3''-di(methoxycarbonyl)-
5',5''-dichloro-diphenylmethylene)piperidine]-5-
oxopentanoate
c1c(Cl)c(OC)c(C(=O)OC)cc1/C(c2cc(C(=O)OC)c(OC)c(Cl)c2)=C3/CCN(C(=O)OCCCC(=O)
OC)CC3
4148 C30H33IN2O TAK-779 derivative; T-4053-002 c1ccccc1c2ccc3CCC(=Cc3c2)C(=O)Nc4ccc(cc4)C[N+]5(C)CCCCC5.[I-]
4149 C30H33IN2O quaternary ammonium salt; 4128-102 c1ccccc1c2ccc3CCC(=Cc3c2)C(=O)Nc4ccc(cc4)C[N+]5(CCCCC5)C.[I-]
4150 C30H33IN2O2 quaternary ammonium salt; 4128-109 c1cc(C)ccc1c2ccc3OCC(=Cc3c2)C(=O)Nc4ccc(cc4)C[N+]5(C)CCCCC5.[I-]
4151 C30H33N3O5S HIV protease inhibitor; 4069-011 c1ccccc1CC(CC)cC2=CC(O)=C(C(=O)O2)C(C3CC3)c4cccc(c4)NS(=O)(=O)c5ncn(C)c5
3-amino-2-hydroxy-4-phenylbutanoic acid deriv.; T- c12ccccc2cccc1C(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N3C[C@@H](Cl)C[C@H]3C(
4152 C30H34ClN3O4 4442-038
=O)NC(C)(C)C
4153 C30H34ClN3O4
3-amino-2-hydroxy-4-phenylbutanoic acid deriv.; T-
4442-039
4154 C30H34N2O6 4-aryl-1,4-dihydropyridine dimer; T-4199-007
c1c2ccccc2ccc1C(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N3C[C@@H](Cl)C[C@H]3C(
=O)NC(C)(C)C
[C@]36(CO)[C@]2([H])[N@](C(=O)C)[C@]5([H])[C@]4(CO)[C@@]([H])(c1ccccc1)[C@@]2(
CO)[C@]3([H])[N@](C(=O)C)[C@]4([H])[C@]5(CO)[C@]6([H])c7ccccc7